Reversing oral anticoagulants with a focus on Andexanet Alfa
20:59
Anticoagulant Reversal
7:55
Reversal of Direct Oral Anticoagulants
1:00:02
Innovative modes for anticoagulation and VTE care
1:00:57
Update on Andexanet Alfa for Reversal of FXa Inhibitors: Annexa-I Trial Webinar
58:43
DOACs in extremes of body weight
50:55
Choosing Wisely to Achieve Control With BTK Inhibitors in CLL
12:09
Oral Anticoagulants || Warfarin || Rivaroxaban || Apixiban || Dabigatran
27:51